| Company | Ticker | Filing | DATE | FP | FY | End Date | URL | VIEW | |
|---|---|---|---|---|---|---|---|---|---|
| HomesToLife Ltd | HTLM | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| Propanc Biopharma, Inc. | PPCB | S-1/A | 4/8/2025 | Q2 | 2025 | 12/31/2024 | SEC | view | |
| Tilray Brands, Inc. | TLRY | 10-Q | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | |
| GLEN BURNIE BANCORP | GLBZ | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| Hepion Pharmaceuticals, Inc. | HEPA | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| NIO Inc. | NIO | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| Jingbo Technology, Inc. | SVMB | 10-K/A | 4/8/2025 | Q4 | 2024 | 2/29/2024 | SEC | view | |
| AEHR TEST SYSTEMS | AEHR | 8-K | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | data |
| GOLD RESOURCE CORP | GORO | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| CAPSTONE COMPANIES, INC. | CAPC | 10-K/A | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| TECHPRECISION CORP | TPCS | 10-Q | 4/8/2025 | Q3 | 2025 | 12/31/2024 | SEC | view | |
| BIOLIFE SOLUTIONS INC | BLFS | 10-K/A | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| CAL-MAINE FOODS INC | CALM | 10-Q | 4/8/2025 | Q3 | 2025 | 3/1/2025 | SEC | view | |
| KURA SUSHI USA, INC. | KRUS | 10-Q | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| Karman Holdings Inc. | KRMN | 8-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | data |
| Vision Marine Technologies Inc. | VMAR | 6-K | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| Mama's Creations, Inc. | MAMA | 10-K | 4/8/2025 | Q4 | 2025 | 1/31/2025 | SEC | view | |
| CAL-MAINE FOODS INC | CALM | 8-K | 4/8/2025 | Q3 | 2025 | 3/1/2025 | SEC | view | data |
| KURA SUSHI USA, INC. | KRUS | 8-K | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | data |
| TECHPRECISION CORP | TPCS | 8-K | 4/8/2025 | Q4 | 2025 | 3/31/2025 | SEC | view | data |
| Mama's Creations, Inc. | MAMA | 8-K | 4/8/2025 | Q4 | 2025 | 1/31/2025 | SEC | view | data |
| Nurix Therapeutics, Inc. | NRIX | 10-Q | 4/8/2025 | Q1 | 2025 | 2/28/2025 | SEC | view | |
| GREENBRIER COMPANIES INC | GBX | 10-Q | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| Nurix Therapeutics, Inc. | NRIX | 8-K | 4/8/2025 | Q1 | 2025 | 2/28/2025 | SEC | view | data |
| BIOFORCE NANOSCIENCES HOLDINGS, INC. | BFNH | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| FRANKLIN COVEY CO | FC | 10-Q | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| MILLICOM INTERNATIONAL CELLULAR SA | TIGO | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| RPM INTERNATIONAL INC/DE/ | RPM | 10-Q | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | |
| Ocean Biomedical, Inc. | OCEA | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| Bank Of South Carolina Corp | BKSC | WIREPR | 4/8/2025 | Q4 | 2024 | 3/30/2025 | WIRE | view | data |
| Axil Brands, Inc. | AXIL | 10-Q | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | |
| Axil Brands, Inc. | AXIL | 8-K | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | data |
| JABIL INC | JBL | 10-Q | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| Walgreens Boots Alliance, Inc. | WBA | 10-Q | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | |
| WD 40 CO | WDFC | 8-K | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | data |
| Walgreens Boots Alliance, Inc. | WBA | 8-K | 4/8/2025 | Q2 | 2025 | 2/28/2025 | SEC | view | data |
| Tilray Brands, Inc. | TLRY | 8-K | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | data |
| RPM INTERNATIONAL INC/DE/ | RPM | 8-K | 4/8/2025 | Q3 | 2025 | 2/28/2025 | SEC | view | data |
| Ameritek Ventures, Inc. | CIK0001530185 | 10-K | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| YY Group Holding Ltd. | YYGH | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| DIXIE GROUP INC | DXYN | 10-K | 4/8/2025 | Q4 | 2024 | 12/28/2024 | SEC | view | |
| NeuroSense Therapeutics Ltd. | NRSN | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| HomesToLife Ltd | HTLM | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view | |
| Pharvaris N.V. | PHVS | 20-F | 4/8/2025 | Q4 | 2024 | 12/31/2024 | SEC | view |